These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2116935)

  • 1. Splenic hemorrhage: a complication of tissue plasminogen activator treatment.
    Cheung PK; Arnold JM; McLarty TD
    Can J Cardiol; 1990 Jun; 6(5):183-5. PubMed ID: 2116935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splenic hemorrhage after tissue plasminogen activator for acute myocardial infarction.
    Blankenship J; Indeck M
    N Engl J Med; 1991 Sep; 325(13):969. PubMed ID: 1908949
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemorrhagic upper extremity complications from tissue plasminogen activator.
    Crick KA; Crick JC; Pulley MT
    J Surg Orthop Adv; 2007; 16(1):27-30. PubMed ID: 17371644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaphylactoid reaction during an infusion of recombinant tissue-type plasminogen activator for acute myocardial infarction.
    Massel D; Gill JB; Cairns JA
    Can J Cardiol; 1991 Sep; 7(7):298-302. PubMed ID: 1933636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolytic therapy in cardiogenic shock: effect of increased aortic pressure and rapid tPA administration.
    Garber PJ; Mathieson AL; Ducas J; Patton JN; Geddes JS; Prewitt RM
    Can J Cardiol; 1995 Jan; 11(1):30-6. PubMed ID: 7850662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracerebral hemorrhage after thrombolytic therapy managed with ventricular drainage.
    Al-Khawaja D; Eslick GD; Fuller SJ; Seex K
    J Clin Neurosci; 2007 Sep; 14(9):898-900. PubMed ID: 17660059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture].
    Sakai M; Imai T; Kuboki K; Maeda S; Ueda S; Kuwajima I; Ohkawa S; Matsushita S
    J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemorrhagic ocular complications associated with the use of systemic thrombolytic agents.
    Chorich LJ; Derick RJ; Chambers RB; Cahill KV; Quartetti EJ; Fry JA; Bush CA
    Ophthalmology; 1998 Mar; 105(3):428-31. PubMed ID: 9499772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case history: successful thrombolytic therapy in a patient with acute myocardial infarction.
    Sait YR
    Heart Lung; 1988 Nov; 17(6 Pt 2):782-6. PubMed ID: 3142824
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thrombolytic therapy for myocardial infarction in oral anticoagulation].
    Pizzulli L; Lüderitz B
    Dtsch Med Wochenschr; 1996 Mar; 121(13):424. PubMed ID: 8681737
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thrombolytic therapy in acute myocardial infarct and pulmonary artery thromboembolism].
    Iakovlev VB; Gospodarenko AL; Makarenko AS
    Voen Med Zh; 1993 Jun; (6):45-7. PubMed ID: 8367952
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pulmonary hemorrhage and acute respiratory failure secondary to thrombolytic treatment with tissue plasminogen activator (rt-PA) in patients with acute myocardial infarction].
    Sandar Núñez D; Ruiz Santana S; García Jiménez A; Castro Mao M
    Med Clin (Barc); 1997 Mar; 108(8):318. PubMed ID: 9121219
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intracranial hemorrhage following second thrombolytic treatment of myocardial reinfarction].
    Valentín Segura V; Valls Grima F; Broch Porcar MJ; Miralles Serrano L; Olivares Toledo D; Alvarez Cebrián F
    Rev Esp Cardiol; 1994 Dec; 47(12):836-8. PubMed ID: 7855379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulating appropriate nursing diagnoses for the patient receiving tissue-type plasminogen activator.
    Brooks-Brunn JA
    Heart Lung; 1987 Nov; 16(6 Pt 2):787-91. PubMed ID: 3119523
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anaphylactoid reaction during administration of tissue plasminogen activator (t-PA)].
    Cannas S; De Leo A; Marzari A
    G Ital Cardiol; 1997 Mar; 27(3):278-80. PubMed ID: 9244730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clopidogrel-rt-PA-heparin combination in the treatment of acute myocardial infarction.
    Bassand JP; Cariou R; Grollier G; Kragten J; Wolf JE; Heyndrickx GR
    Semin Thromb Hemost; 1999; 25 Suppl 2():69-75. PubMed ID: 10440428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute myocardial infarction with recombinant tissue-type plasminogen activator.
    Glazier JJ; Crowley J; Cremin D; Coll T; Daly K
    Ir Med J; 1989 Sep; 82(3):111-4. PubMed ID: 2513287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary angioplasty with routine stenting compared with thrombolytic therapy in elderly patients with acute myocardial infarction.
    Goldenberg I; Matetzky S; Halkin A; Roth A; Di Segni E; Freimark D; Elian D; Agranat O; Har Zahav Y; Guetta V; Hod H
    Am Heart J; 2003 May; 145(5):862-7. PubMed ID: 12766745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.